Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OLAPARIB Cause Multiple organ dysfunction syndrome? 26 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Multiple organ dysfunction syndrome have been filed in association with OLAPARIB (Lynparza). This represents 0.1% of all adverse event reports for OLAPARIB.

26
Reports of Multiple organ dysfunction syndrome with OLAPARIB
0.1%
of all OLAPARIB reports
23
Deaths
9
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From OLAPARIB?

Of the 26 reports, 23 (88.5%) resulted in death, 9 (34.6%) required hospitalization, and 5 (19.2%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 26 reports have been filed with the FAERS database.

What Other Side Effects Does OLAPARIB Cause?

Death (4,378) Malignant neoplasm progression (1,862) Nausea (1,582) Anaemia (1,455) Fatigue (1,437) Off label use (777) Vomiting (642) Drug ineffective (563) Diarrhoea (514) Asthenia (491)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which OLAPARIB Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

OLAPARIB vs OLARATUMAB OLAPARIB vs OLECLUMAB OLAPARIB vs OLIVE OIL\SOYBEAN OIL OLAPARIB vs OLMESARTAN OLAPARIB vs OLMESARTAN MEDOXOMIL

Related Pages

OLAPARIB Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome OLAPARIB Demographics